ResearcherHospital Clínic de BarcelonaNo recent work listed

Carme Font

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3547-7373; OpenAlex author ID A5083465159. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

Mild forms of thrombotic microangiopathy in patients with advanced pancreatic cancer receiving gemcitabine and nab-paclitaxel. Last author DOI 10.1177/10781552221114653 ↗
Clinical Course of Venous Thromboembolism in Patients with Pancreatic Cancer: Insights from the RIETE Registry. Co-author DOI 10.1055/s-0038-1642009 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Marta García de Herreros · 1 shared paper, 2023 · strength 0.26
- Paper Mild forms of thrombotic microangiopathy in patients with advanced pancreatic cancer receiving gemcitabine and nab-pacl… DOI 10.1177/10781552221114653 ↗
Corinne Frère · 1 shared paper, 2018 · strength 0.08
- Paper Clinical Course of Venous Thromboembolism in Patients with Pancreatic Cancer: Insights from the RIETE Registry. DOI 10.1055/s-0038-1642009 ↗
Dominique Farge Bancel · 1 shared paper, 2018 · strength 0.08
- Paper Clinical Course of Venous Thromboembolism in Patients with Pancreatic Cancer: Insights from the RIETE Registry. DOI 10.1055/s-0038-1642009 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.